[Experiences with a migraine compound in medical practice. A multicenter study with Avamigran].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000632:Aminopyrine / Q000627:therapeutic use*; D000700:Analgesics / Q000627:therapeutic use*; D002110:Caffeine; D002986:Clinical Trials as Topic; D004338:Drug Combinations / Q000627:therapeutic use; D004878:Ergotamine / Q000627:therapeutic use*; D005998:Glycine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D011437:Propylamines / Q000627:therapeutic use*; D047069:Pyrazolones
D000700:Analgesics; D004338:Drug Combinations; D011437:Propylamines; D047069:Pyrazolones; C002926:caffeine, camylofin, ergotamine, mecloxamine, propyphenazone drug combination; D000632:Aminopyrine; D002110:Caffeine; D004878:Ergotamine; D005998:Glycine
Erfahrungen mit einem Migränemittel in der ärztlichen Praxis. Eine Multicenter-Studie mit Avamigran.